Keyword: Temple University
Renovacor is working on a gene therapy for small group of patients with dilated cardiomyopathy that could spare them from a heart transplant.
A TGen-led research team found that increased activity of the gene AEBP1 drives severe liver fibrosis in nonalcoholic steatohepatitis.
A team of scientists has cleared HIV from infected mice using CRISPR-Cas9 and a long-acting antiretroviral therapy.
The deal gives Excision the exclusive right to use the recently discovered Cas9 alternatives to treat infectious diseases.
A new CAR-T approach controlled HIV spread and protected T cells from being attacked by HIV in mouse models.
Stemcentrx backer Artis Ventures led the $10 million seed round to equip Excision to start human testing of its CRISPR-enabled attack on latent HIV.
Most research aimed at finding an HIV cure is focused on wiping out the virus from immune cells, but a new discovery suggests a different approach is in order.
